Table 5

The prevalence of geographic atrophy or neovascular AMD in the Hisayama study

Age (years)FemaleMaleTotal
No% FreqNo% FreqNo% Freq
Geographic atrophy50–59285015504400
60–6933402310.875650.35
70–79211018003910
80+580323.1901.1
Total88905970.5014860.20
Neovascular AMD50–592850.7015504400.45
60–693340.302311.75650.88
70–7921101801.13910.51
80+580323.1901.1
Total8890.345971.214860.67